AKADEEMILINE ÕENDUSLUGU
Urol 2005;66:96470.
Di Silverio F, Gentile V, De Matteis A, et al. Distribution of inf lammation, pre-
malignant lesions, incidental carcinoma in histologically confirmed benign prostatic
hyperplasia: a retrospec tive analysis. Eur Urol 2003;43:16475.
Gleason PE, Jones JA, Regan JS, et al. Platelet derived growth factor, a ndrogens and
inflammation: possible etiologic factors in the development of prostatitis
hyperplasia. J Urol 1993;149:158690.
Kramer G, Steiner GE, Handisurya A, et al. Increased expression of lymphocyte-
derived cytokines in benign hyperplastic prostate tissue, identif ication of the
producing cell types, and effect of differentially expressed cytokines on stromal cell
proliferation. Prostate 2002;52:4358.
King, C. (2012). Rehabilitation After Hip Fracture in Patsients with Dementia.
Nursing Older People Journal. Vol: 24(7) 33-36
Lepor H. Alpha blockade for the treatment of benign prostatic hyperplasia. Urol Clin
N Am 1995;22:37586.